annual CFI:
$136.49M+$247.74M(+222.70%)Summary
- As of today (June 28, 2025), BMRN annual cash flow from investing activities is $136.49 million, with the most recent change of +$247.74 million (+222.70%) on December 31, 2024.
- During the last 3 years, BMRN annual CFI has risen by +$502.80 million (+137.26%).
- BMRN annual CFI is now -48.37% below its all-time high of $264.35 million, reached on December 31, 2018.
Performance
BMRN Cash from investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFI:
-$28.24M-$104.64M(-136.96%)Summary
- As of today (June 28, 2025), BMRN quarterly cash flow from investing activities is -$28.24 million, with the most recent change of -$104.64 million (-136.96%) on March 31, 2025.
- Over the past year, BMRN quarterly CFI has dropped by -$14.00 million (-98.36%).
- BMRN quarterly CFI is now -106.10% below its all-time high of $462.68 million, reached on December 31, 2014.
Performance
BMRN quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFI:
$122.49M-$14.00M(-10.26%)Summary
- As of today (June 28, 2025), BMRN TTM cash flow from investing activities is $122.49 million, with the most recent change of -$14.00 million (-10.26%) on March 31, 2025.
- Over the past year, BMRN TTM CFI has increased by +$217.96 million (+228.30%).
- BMRN TTM CFI is now -74.21% below its all-time high of $474.86 million, reached on September 30, 2018.
Performance
BMRN TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
BMRN Cash from investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +222.7% | -98.4% | +228.3% |
| 3 y3 years | +137.3% | -132.2% | +159.0% |
| 5 y5 years | +539.9% | -136.5% | +26.5% |
BMRN Cash from investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +137.3% | -131.2% | +56.5% | -10.3% | +159.0% |
| 5 y | 5-year | at high | +137.3% | -126.5% | +88.7% | -10.3% | +133.4% |
| alltime | all time | -48.4% | +111.6% | -106.1% | +96.2% | -74.2% | +110.4% |
BMRN Cash from investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$28.24M(-137.0%) | $122.49M(-10.3%) |
| Dec 2024 | $136.49M(-222.7%) | $76.40M(-572.9%) | $136.49M(-2899.2%) |
| Sep 2024 | - | -$16.16M(-117.9%) | -$4.88M(-85.9%) |
| Jun 2024 | - | $90.48M(-735.6%) | -$34.52M(-63.8%) |
| Mar 2024 | - | -$14.24M(-78.1%) | -$95.47M(-14.2%) |
| Dec 2023 | -$111.24M(+455.4%) | -$64.96M(+41.8%) | -$111.24M(+10.2%) |
| Sep 2023 | - | -$45.80M(-255.1%) | -$100.99M(+28.5%) |
| Jun 2023 | - | $29.53M(-198.4%) | -$78.59M(-43.0%) |
| Mar 2023 | - | -$30.01M(-45.1%) | -$137.82M(+588.1%) |
| Dec 2022 | -$20.03M(-94.5%) | -$54.71M(+133.8%) | -$20.03M(-3.4%) |
| Sep 2022 | - | -$23.40M(-21.2%) | -$20.74M(-82.3%) |
| Jun 2022 | - | -$29.70M(-133.8%) | -$117.19M(-43.6%) |
| Mar 2022 | - | $87.78M(-258.4%) | -$207.74M(-43.3%) |
| Dec 2021 | -$366.31M(+583.2%) | -$55.42M(-53.8%) | -$366.31M(+22.2%) |
| Sep 2021 | - | -$119.85M(-0.3%) | -$299.87M(+309.0%) |
| Jun 2021 | - | -$120.26M(+69.9%) | -$73.32M(-63.7%) |
| Mar 2021 | - | -$70.79M(-742.0%) | -$201.81M(+276.4%) |
| Dec 2020 | -$53.62M(+72.8%) | $11.03M(-89.7%) | -$53.62M(-52.8%) |
| Sep 2020 | - | $106.70M(-142.9%) | -$113.54M(-33.8%) |
| Jun 2020 | - | -$248.75M(-421.4%) | -$171.56M(-277.1%) |
| Mar 2020 | - | $77.40M(-258.3%) | $96.86M(-412.2%) |
| Dec 2019 | -$31.03M(-111.7%) | -$48.90M(-200.4%) | -$31.03M(-41.6%) |
| Sep 2019 | - | $48.68M(+147.5%) | -$53.09M(-117.7%) |
| Jun 2019 | - | $19.67M(-139.0%) | $300.56M(+5.2%) |
| Mar 2019 | - | -$50.48M(-28.9%) | $285.61M(+8.0%) |
| Dec 2018 | $264.35M(-186.5%) | -$70.96M(-117.6%) | $264.35M(-44.3%) |
| Sep 2018 | - | $402.33M(+8420.2%) | $474.86M(-232.8%) |
| Jun 2018 | - | $4.72M(-106.6%) | -$357.69M(-11.1%) |
| Mar 2018 | - | -$71.73M(-151.4%) | -$402.24M(+31.7%) |
| Dec 2017 | -$305.46M(-36.9%) | $139.55M(-132.4%) | -$305.46M(-59.5%) |
| Sep 2017 | - | -$430.23M(+980.4%) | -$754.65M(+15.9%) |
| Jun 2017 | - | -$39.82M(-259.0%) | -$651.36M(+21.5%) |
| Mar 2017 | - | $25.05M(-108.1%) | -$536.00M(+10.7%) |
| Dec 2016 | -$484.05M(-59.0%) | -$309.65M(-5.3%) | -$484.05M(+410.3%) |
| Sep 2016 | - | -$326.94M(-532.8%) | -$94.85M(-156.1%) |
| Jun 2016 | - | $75.54M(-1.9%) | $169.01M(-148.1%) |
| Mar 2016 | - | $77.00M(-3.2%) | -$351.73M(-70.2%) |
| Dec 2015 | -$1.18B(-700.8%) | $79.55M(-226.1%) | -$1.18B(+48.1%) |
| Sep 2015 | - | -$63.08M(-85.8%) | -$796.47M(-13.5%) |
| Jun 2015 | - | -$445.20M(-40.7%) | -$920.86M(+78.5%) |
| Mar 2015 | - | -$750.87M(-262.3%) | -$516.02M(-362.8%) |
| Dec 2014 | $196.33M(-165.7%) | $462.68M(-346.8%) | $196.33M(-134.3%) |
| Sep 2014 | - | -$187.48M(+364.5%) | -$572.84M(+49.9%) |
| Jun 2014 | - | -$40.36M(+4.8%) | -$382.05M(+16.0%) |
| Mar 2014 | - | -$38.52M(-87.4%) | -$329.43M(+10.2%) |
| Dec 2013 | -$298.85M(+52.8%) | -$306.49M(-9351.0%) | -$298.85M(+568.3%) |
| Sep 2013 | - | $3.31M(-73.0%) | -$44.72M(-35.2%) |
| Jun 2013 | - | $12.26M(-254.4%) | -$68.98M(-70.5%) |
| Mar 2013 | - | -$7.94M(-84.8%) | -$233.62M(+19.4%) |
| Dec 2012 | -$195.65M(+118.5%) | -$52.35M(+149.9%) | -$195.65M(+9.8%) |
| Sep 2012 | - | -$20.95M(-86.3%) | -$178.21M(-17.3%) |
| Jun 2012 | - | -$152.38M(-607.3%) | -$215.58M(+245.0%) |
| Mar 2012 | - | $30.04M(-186.0%) | -$62.49M(-30.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2011 | -$89.56M(-11.6%) | -$34.91M(-40.1%) | -$89.56M(+31.2%) |
| Sep 2011 | - | -$58.32M(-8360.8%) | -$68.26M(+389.6%) |
| Jun 2011 | - | $706.00K(-76.2%) | -$13.94M(-49.8%) |
| Mar 2011 | - | $2.97M(-121.8%) | -$27.77M(-72.6%) |
| Dec 2010 | -$101.34M(+27.2%) | -$13.61M(+239.8%) | -$101.34M(-23.9%) |
| Sep 2010 | - | -$4.00M(-69.5%) | -$133.25M(-22.3%) |
| Jun 2010 | - | -$13.13M(-81.4%) | -$171.47M(+39.9%) |
| Mar 2010 | - | -$70.60M(+55.1%) | -$122.58M(+53.9%) |
| Dec 2009 | -$79.67M(+317.6%) | -$45.52M(+7.8%) | -$79.67M(-9.5%) |
| Sep 2009 | - | -$42.23M(-218.1%) | -$88.03M(+166.1%) |
| Jun 2009 | - | $35.76M(-229.2%) | -$33.09M(-77.7%) |
| Mar 2009 | - | -$27.69M(-48.6%) | -$148.13M(+676.5%) |
| Dec 2008 | -$19.08M(-87.4%) | -$53.88M(-523.7%) | -$19.08M(-44.1%) |
| Sep 2008 | - | $12.72M(-116.0%) | -$34.13M(-176.2%) |
| Jun 2008 | - | -$79.28M(-178.2%) | $44.77M(-156.5%) |
| Mar 2008 | - | $101.36M(-247.0%) | -$79.26M(-47.5%) |
| Dec 2007 | -$151.00M(-21.6%) | -$68.94M(-175.2%) | -$151.00M(-12.7%) |
| Sep 2007 | - | $91.63M(-145.1%) | -$172.97M(-50.5%) |
| Jun 2007 | - | -$203.31M(-786.3%) | -$349.24M(+100.8%) |
| Mar 2007 | - | $29.63M(-132.6%) | -$173.90M(-9.8%) |
| Dec 2006 | -$192.69M(-456.3%) | -$90.91M(+7.4%) | -$192.69M(+83.1%) |
| Sep 2006 | - | -$84.65M(+202.7%) | -$105.22M(+498.5%) |
| Jun 2006 | - | -$27.96M(-358.2%) | -$17.58M(-152.0%) |
| Mar 2006 | - | $10.83M(-414.9%) | $33.84M(-37.4%) |
| Dec 2005 | $54.07M(-284.0%) | -$3.44M(-215.1%) | $54.07M(-15.2%) |
| Sep 2005 | - | $2.99M(-87.3%) | $63.76M(-12.6%) |
| Jun 2005 | - | $23.45M(-24.5%) | $72.98M(+389.7%) |
| Mar 2005 | - | $31.07M(+397.3%) | $14.90M(-150.7%) |
| Dec 2004 | -$29.38M(-42.3%) | $6.25M(-48.8%) | -$29.38M(-58.0%) |
| Sep 2004 | - | $12.21M(-135.3%) | -$70.01M(-25.3%) |
| Jun 2004 | - | -$34.62M(+161.9%) | -$93.66M(+14.8%) |
| Mar 2004 | - | -$13.22M(-61.6%) | -$81.58M(+60.1%) |
| Dec 2003 | -$50.95M(-171.9%) | -$34.38M(+200.3%) | -$50.95M(-399.2%) |
| Sep 2003 | - | -$11.45M(-49.2%) | $17.03M(-63.2%) |
| Jun 2003 | - | -$22.54M(-229.4%) | $46.31M(-37.5%) |
| Mar 2003 | - | $17.42M(-48.2%) | $74.13M(+4.5%) |
| Dec 2002 | $70.91M(-161.1%) | $33.60M(+88.5%) | $70.91M(-274.0%) |
| Sep 2002 | - | $17.83M(+237.5%) | -$40.74M(-38.4%) |
| Jun 2002 | - | $5.28M(-62.8%) | -$66.16M(-41.5%) |
| Mar 2002 | - | $14.20M(-118.2%) | -$113.03M(-2.7%) |
| Dec 2001 | -$116.13M(+6663.5%) | -$78.05M(+928.6%) | -$116.13M(+229.2%) |
| Sep 2001 | - | -$7.59M(-81.8%) | -$35.27M(+42.3%) |
| Jun 2001 | - | -$41.59M(-474.8%) | -$24.78M(+127.1%) |
| Mar 2001 | - | $11.10M(+295.3%) | -$10.91M(+535.5%) |
| Dec 2000 | -$1.72M(-97.5%) | $2.81M(-3.3%) | -$1.72M(-83.8%) |
| Sep 2000 | - | $2.90M(-110.5%) | -$10.57M(-83.0%) |
| Jun 2000 | - | -$27.72M(-236.6%) | -$62.28M(+33.2%) |
| Mar 2000 | - | $20.29M(-435.4%) | -$46.76M(-32.0%) |
| Dec 1999 | -$68.75M(+738.4%) | -$6.05M(-87.6%) | -$68.75M(+9.6%) |
| Sep 1999 | - | -$48.80M(+300.0%) | -$62.70M(+351.1%) |
| Jun 1999 | - | -$12.20M(+617.2%) | -$13.90M(+717.2%) |
| Mar 1999 | - | -$1.70M | -$1.70M |
| Dec 1998 | -$8.20M | - | - |
FAQ
- What is BioMarin Pharmaceutical annual cash flow from investing activities?
- What is the all time high annual CFI for BioMarin Pharmaceutical?
- What is BioMarin Pharmaceutical annual CFI year-on-year change?
- What is BioMarin Pharmaceutical quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for BioMarin Pharmaceutical?
- What is BioMarin Pharmaceutical quarterly CFI year-on-year change?
- What is BioMarin Pharmaceutical TTM cash flow from investing activities?
- What is the all time high TTM CFI for BioMarin Pharmaceutical?
- What is BioMarin Pharmaceutical TTM CFI year-on-year change?
What is BioMarin Pharmaceutical annual cash flow from investing activities?
The current annual CFI of BMRN is $136.49M
What is the all time high annual CFI for BioMarin Pharmaceutical?
BioMarin Pharmaceutical all-time high annual cash flow from investing activities is $264.35M
What is BioMarin Pharmaceutical annual CFI year-on-year change?
Over the past year, BMRN annual cash flow from investing activities has changed by +$247.74M (+222.70%)
What is BioMarin Pharmaceutical quarterly cash flow from investing activities?
The current quarterly CFI of BMRN is -$28.24M
What is the all time high quarterly CFI for BioMarin Pharmaceutical?
BioMarin Pharmaceutical all-time high quarterly cash flow from investing activities is $462.68M
What is BioMarin Pharmaceutical quarterly CFI year-on-year change?
Over the past year, BMRN quarterly cash flow from investing activities has changed by -$14.00M (-98.36%)
What is BioMarin Pharmaceutical TTM cash flow from investing activities?
The current TTM CFI of BMRN is $122.49M
What is the all time high TTM CFI for BioMarin Pharmaceutical?
BioMarin Pharmaceutical all-time high TTM cash flow from investing activities is $474.86M
What is BioMarin Pharmaceutical TTM CFI year-on-year change?
Over the past year, BMRN TTM cash flow from investing activities has changed by +$217.96M (+228.30%)